Dalbagni, Guido

Publications

Sort by

Co-Author Network

selected publications

Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma. European urology. 2020 Academic Article GET IT
Times cited: 29
Goal-directed versus Standard Fluid Therapy to Decrease Ileus after Open Radical Cystectomy: A Prospective Randomized Controlled Trial. Anesthesiology. 2020 Academic Article GET IT
Times cited: 29
The impact of fluid optimisation before induction of anaesthesia on hypotension after induction. Anaesthesia. 2020 Academic Article GET IT
Times cited: 32
Reply to Siebren Dijkstra and Carl J. Wijburg's Letter to the Editor re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. Eur Urol 2018;74:465-71. Can the Pattern of Cancer Recurrence Truly be Assigned to the Surgical Modality?. European urology. 2019 Article GET IT
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 183
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy. World journal of urology. 2018 Academic Article GET IT
Times cited: 15
Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. European urology. 2018 Academic Article GET IT
Times cited: 218
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Academic Article GET IT
Times cited: 114
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. World journal of urology. 2018 Academic Article GET IT
Times cited: 30
Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma. Urologic oncology. 2016 Academic Article GET IT
Times cited: 11
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer. Urologic oncology. 2016 Academic Article GET IT
Times cited: 59
Preoperative Nutritional Status and The Impact on Radical Cystectomy Recovery: An International Comparative Study. Urologic nursing. 2016 Academic Article GET IT
Times cited: 8
Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution. World journal of urology. 2016 Academic Article GET IT
Times cited: 7
A 10-Item Checklist Improves Reporting of Critical Procedural Elements during Transurethral Resection of Bladder Tumor. The Journal of urology. 2016 Academic Article GET IT
Times cited: 51
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer. Nature genetics. 2016 Academic Article GET IT
Times cited: 145
The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cm. Urologic oncology. 2016 Academic Article GET IT
Times cited: 28
Idiographic quality of life assessment before radical cystectomy. Psycho-oncology. 2015 Academic Article GET IT
Times cited: 7
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin. BJU international. 2015 Academic Article GET IT
Times cited: 118
Genomic Characterization of Upper Tract Urothelial Carcinoma. European urology. 2015 Academic Article GET IT
Times cited: 210
BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: a prospective cohort outcomes study. Urologic oncology. 2015 Academic Article GET IT
Times cited: 28
Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. European urology. 2014 Academic Article GET IT
Times cited: 510
Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. BJU international. 2014 Academic Article GET IT
Times cited: 29
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. European urology. 2014 Academic Article GET IT
Times cited: 142
Adherence to surveillance guidelines after radical cystectomy: a population-based analysis. Urologic oncology. 2014 Academic Article GET IT
Times cited: 5
External beam radiation therapy for small cell carcinoma of the urinary bladder. Practical radiation oncology. 2014 Academic Article GET IT
Times cited: 15
Postoperative nomogram for disease recurrence and cancer-specific death for upper tract urothelial carcinoma: comparison to American Joint Committee on Cancer staging classification. Urology journal. 2014 Academic Article GET IT
Times cited: 19
Prospective evaluation of plasma kinetic bipolar resection of bladder cancer: comparison to monopolar resection and pathologic findings. International urology and nephrology. 2014 Academic Article GET IT
Times cited: 32
Contemporary management of penile cancer: greater than 15 year MSKCC experience. The Canadian journal of urology. 2014 Academic Article GET IT
Times cited: 31
Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder. The Journal of urology. 2014 Academic Article GET IT
Times cited: 69
Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy. BJU international. 2014 Academic Article GET IT
Times cited: 30
Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU international. 2014 Information Resource GET IT
Times cited: 166
Risk factors for the development of parastomal hernia after radical cystectomy. The Journal of urology. 2013 Academic Article GET IT
Times cited: 78
The prevalence of persistent prostate cancer after radiotherapy detected at radical cystoprostatectomy for bladder cancer. The Journal of urology. 2013 Academic Article GET IT
Times cited: 3
Non-squamous cell carcinoma of the penis: single-center, 15-year experience. World journal of urology. 2013 Academic Article GET IT
Times cited: 13
The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. World journal of urology. 2013 Academic Article GET IT
Times cited: 28
Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer. The Journal of urology. 2013 Academic Article GET IT
Times cited: 25
Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure. The Journal of urology. 2013 Academic Article GET IT
Times cited: 30
Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer. BJU international. 2013 Academic Article GET IT
Times cited: 55
Intravesical bacille Calmette-Guérin (BCG) in immunologically compromised patients with bladder cancer. BJU international. 2013 Academic Article GET IT
Times cited: 20
Management of bladder cancer after renal transplantation. Urology. 2013 Academic Article GET IT
Times cited: 19
Preoperative accuracy of diagnostic evaluation of the urachal mass. The Journal of urology. 2012 Academic Article GET IT
Times cited: 21
Urinary diversion practice patterns among certifying American urologists. The Journal of urology. 2012 Academic Article GET IT
Times cited: 15
Treatment options available for bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer. European urology. 2012 Information Resource GET IT
Times cited: 61
Prospective evaluation of MRI, ¹¹C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer. European journal of radiology. 2012 Academic Article GET IT
Times cited: 45
Epidemiology and risk factors of urothelial bladder cancer. European urology. 2012 Information Resource GET IT
Times cited: 1099
Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma. BJU international. 2012 Academic Article GET IT
Times cited: 23
Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature. European urology. 2012 Information Resource GET IT
Times cited: 64
Management of postoperative lymphoceles after lymphadenectomy: percutaneous catheter drainage with and without povidone-iodine sclerotherapy. Cardiovascular and interventional radiology. 2012 Academic Article GET IT
Times cited: 28
Initial results with (11)C-acetate positron emission tomography/computed tomography (PET/CT) in the staging of urinary bladder cancer. Molecular imaging and biology. 2012 Academic Article GET IT
Times cited: 39
Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. European urology. 2012 Academic Article GET IT
Times cited: 96
Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma. The Journal of urology. 2011 Academic Article GET IT
Times cited: 36
Comparison of open and minimally invasive partial nephrectomy for renal tumors 4-7 centimeters. European urology. 2011 Academic Article GET IT
Times cited: 81
Urine markers for detection and surveillance of non-muscle-invasive bladder cancer. European urology. 2011 Information Resource GET IT
Times cited: 129
Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU international. 2011 Academic Article GET IT
Times cited: 165
Is 'second-look' (re-staging) transurethral resection of bladder tumours a new standard of care?. Arab journal of urology. 2011 Information Resource GET IT
Times cited: 1
Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma. The Journal of pathology. 2011 Academic Article GET IT
Times cited: 77
A plea for a uniform surveillance schedule after radical cystectomy. The Journal of urology. 2011 Academic Article GET IT
Times cited: 11
Bacillus Calmette-Guérin without maintenance therapy for high-risk non-muscle-invasive bladder cancer. European urology. 2011 Academic Article GET IT
Times cited: 54
The psychological context of quality of life: a psychometric analysis of a novel idiographic measure of bladder cancer patients' personal goals and concerns prior to surgery. Health and quality of life outcomes. 2011 Academic Article GET IT
Times cited: 26
Bladder cancer in cystoscopically normal-appearing mucosa: a case of mistaken identity?. BJU international. 2010 Academic Article GET IT
Times cited: 8
Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma. BJU international. 2010 Academic Article GET IT
Times cited: 11
Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique?. European urology. 2010 Academic Article GET IT
Times cited: 101
The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. European urology. 2010 Academic Article GET IT
Times cited: 156
Clinical outcomes of primary bladder carcinoma in situ in a contemporary series. The Journal of urology. 2010 Academic Article GET IT
Times cited: 49
Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. European urology. 2010 Academic Article GET IT
Times cited: 220
Clinical outcome of primary versus secondary bladder carcinoma in situ. The Journal of urology. 2010 Academic Article GET IT
Times cited: 36
Update on intravesical agents for non-muscle-invasive bladder cancer. Immunotherapy. 2010 Information Resource GET IT
Times cited: 19
Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer. The Journal of urology. 2010 Academic Article GET IT
Times cited: 28
Narrow-band imaging cystoscopy to evaluate bladder tumours--individual surgeon variability. BJU international. 2009 Academic Article GET IT
Times cited: 43
Prognostication of upper tract urothelial carcinoma: what do we really need?. European urology. 2009 Editorial Article GET IT
Times cited: 2
Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach. Cancer. 2009 Academic Article GET IT
Times cited: 29
Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinoma. Cancer. 2009 Academic Article GET IT
Times cited: 12
Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. European urology. 2009 Academic Article GET IT
Times cited: 112
Metastatic renal cell carcinoma risk according to tumor size. The Journal of urology. 2009 Academic Article GET IT
Times cited: 194
Is intravesical bacillus Calmette-Guérin better than mitomycin for intermediate-risk bladder cancer?. European urology. 2009 Editorial Article GET IT
Times cited: 6
Reflex UroVysion testing in suspicious urine cytology cases. Cancer. 2009 Academic Article GET IT
Times cited: 39
Contemporary use of partial nephrectomy at a tertiary care center in the United States. The Journal of urology. 2009 Academic Article GET IT
Times cited: 133
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience. Cancer. 2008 Academic Article GET IT
Times cited: 232
Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. European urology. 2008 Academic Article GET IT
Times cited: 895
Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. European urology. 2008 Academic Article GET IT
Times cited: 170
Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer. 2008 Academic Article GET IT
Times cited: 194
Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. The Journal of urology. 2007 Academic Article GET IT
Times cited: 69
Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. European urology. 2007 Academic Article GET IT
Times cited: 82
Urachal carcinoma: contemporary surgical outcomes. The Journal of urology. 2007 Academic Article GET IT
Times cited: 104
The management of superficial bladder cancer. Nature clinical practice. Urology. 2007 Information Resource GET IT
Times cited: 55
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. The Journal of urology. 2007 Academic Article GET IT
Times cited: 120
The anterior layer of Denonvilliers' fascia: a common misconception in the laparoscopic prostatectomy literature. The Journal of urology. 2007 Academic Article GET IT
Times cited: 36
Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?. The Journal of urology. 2007 Academic Article GET IT
Times cited: 118
Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Information Resource GET IT
Times cited: 77
Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder. BJU international. 2006 Academic Article GET IT
Times cited: 40
Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?. Cancer. 2006 Academic Article GET IT
Times cited: 178
Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis. British journal of cancer. 2006 Academic Article GET IT
Times cited: 21
Natural history of positive urinary cytology after radical cystectomy. The Journal of urology. 2006 Academic Article GET IT
Times cited: 19
Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder. Cancer. 2006 Academic Article GET IT
Times cited: 261
Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients. The Journal of urology. 2006 Academic Article GET IT
Times cited: 38
Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 136
Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract. The Journal of urology. 2006 Academic Article GET IT
Times cited: 6
Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer. 2005 Academic Article GET IT
Times cited: 46
Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?. The Journal of urology. 2005 Academic Article GET IT
Times cited: 53
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. The Journal of urology. 2004 Academic Article GET IT
Times cited: 76
Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. The Journal of urology. 2004 Academic Article GET IT
Times cited: 171
Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. The Journal of urology. 2004 Academic Article GET IT
Times cited: 100
Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2004 Academic Article GET IT
Times cited: 18
Cyclooxygenase-2 and microsomal prostaglandin E synthase-1 are overexpressed in squamous cell carcinoma of the penis. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 83
Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm. The Journal of urology. 2004 Academic Article GET IT
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study. The Journal of urology. 2004 Academic Article GET IT
Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer detection and prevention. 2004 Academic Article GET IT
Times cited: 30
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer. Cancer immunity. 2003 Academic Article GET IT
Times cited: 64
Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2003 Academic Article GET IT
Times cited: 81
Carcinoma in a bladder diverticulum: presentation and treatment outcome. The Journal of urology. 2003 Academic Article GET IT
Times cited: 83
Comparison of bladder cancer survival among Japanese, Chinese, Filipino, Hawaiian and Caucasian populations in the United States. Asian Pacific journal of cancer prevention : APJCP. 2003 Academic Article GET IT
Times cited: 10
Defining bacillus Calmette-Guerin refractory superficial bladder tumors. The Journal of urology. 2003 Academic Article GET IT
Times cited: 142
Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy. The Journal of urology. 2003 Academic Article GET IT
Times cited: 49
Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. The Journal of urology. 2003 Academic Article GET IT
Times cited: 96
Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology. 2002 Academic Article GET IT
Times cited: 94
Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder. The Journal of urology. 2002 Academic Article GET IT
Times cited: 65
Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 144
Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome. The Journal of urology. 2002 Academic Article GET IT
Times cited: 67
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. The Journal of urology. 2002 Academic Article GET IT
Times cited: 494
Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods. Clinical cancer research : an official journal of the American Association for Cancer Research. 2002 Academic Article GET IT
Times cited: 123
Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra. The Journal of urology. 2001 Academic Article GET IT
Times cited: 20
Genetic alterations in tp53 in recurrent urothelial cancer: a longitudinal study. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 32
Cystectomy for bladder cancer: a contemporary series. The Journal of urology. 2001 Academic Article GET IT
Times cited: 372
[Arachidonic acid and prostaglandins, inflammation and oncology]. Presse medicale (Paris, France : 1983). 2001 Article GET IT
Times cited: 14
Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy?. The Journal of urology. 1999 Academic Article GET IT
Times cited: 36
Toxicology and pharmacokinetics of intravesical gemcitabine: a preclinical study in dogs. Clinical cancer research : an official journal of the American Association for Cancer Research. 1999 Academic Article GET IT
Times cited: 58
Male urethral carcinoma: analysis of treatment outcome. Urology. 1999 Academic Article GET IT
Times cited: 104
Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. Journal of the National Cancer Institute. 1999 Academic Article GET IT
Times cited: 66
Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer. Annals of surgical oncology. 1998 Academic Article GET IT
Times cited: 9
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 1997 Academic Article GET IT
Times cited: 62
Genetic studies and molecular markers of bladder cancer. Seminars in surgical oncology. 1997 Information Resource GET IT
Times cited: 52
Chromosome 16 in primary prostate cancer: a microsatellite analysis. International journal of cancer. 1997 Academic Article GET IT
Times cited: 19
Cigarette smoking and chromosome 9 alterations in bladder cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1997 Academic Article GET IT
Times cited: 17
Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer research. 1997 Academic Article GET IT
Times cited: 219
Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study. British journal of urology. 1997 Academic Article GET IT
Times cited: 37
Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer. International journal of cancer. 1996 Academic Article GET IT
Times cited: 36
Comparative study between cytology and dot-ELISA for early detection of bladder cancer. American journal of clinical pathology. 1996 Academic Article GET IT
Times cited: 8
Deletion of the p16 and p15 genes in human bladder tumors. Journal of the National Cancer Institute. 1995 Academic Article GET IT
Times cited: 180
Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practice. Surgical oncology clinics of North America. 1995 Information Resource GET IT
Times cited: 16
Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proceedings of the National Academy of Sciences of the United States of America. 1995 Academic Article GET IT
Times cited: 115
Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. The Journal of urology. 1994 Academic Article GET IT
Times cited: 176
Bladder cancer: advances in biology and treatment. Critical reviews in oncology/hematology. 1994 Information Resource GET IT
Times cited: 7
p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. International journal of cancer. 1994 Academic Article GET IT
Times cited: 220
Clinical follow-up in 24 nonfamilial renal tumors cytogenetically characterized in tissue culture. Urology. 1994 Academic Article GET IT
Times cited: 3
Genetic alterations associated with bladder cancer. Important advances in oncology. 1994 Information Resource GET IT
Times cited: 29
Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1994 Academic Article GET IT
Times cited: 47
Genetic alterations in bladder cancer. Lancet (London, England). 1993 Academic Article GET IT
Times cited: 220
P53 nuclear overexpression and disease progression in ta-bladder carcinoma. International journal of oncology. 1993 Academic Article GET IT
Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diagnostic molecular pathology : the American journal of surgical pathology, part B. 1993 Academic Article GET IT
Times cited: 97
Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. Journal of the National Cancer Institute. 1993 Academic Article GET IT
Times cited: 486
Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. Journal of the National Cancer Institute. 1992 Academic Article GET IT
Times cited: 297
Experience with potency preservation during radical prostatectomy. Significance of learning curve. Urology. 1988 Academic Article GET IT
Times cited: 2
Carcinoma of the pancreas in nonjaundiced patients. A silent disease. The American surgeon. 1985 Academic Article GET IT
Times cited: 7

more ...

less ...

Background

education and training

M.B.,B.Ch., University of Cairo, Faculty of Medicine (Egypt) 79

Contact

full name

Guido Dalbagni

VIVO Weill Cornell Medical College

Guido Dalbagni Professor of Urology

Publications

selected publications

Background

education and training

Contact

full name